Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

February 18, 2014 updated by: National Taiwan University Hospital

A Randomized, Single-blinded, Comparative Study to Evaluate the Efficacy and the Acceptability of Low-residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Study Overview

Detailed Description

In this study, we investigate a randomized, single-blinded, comparative study to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kaohsiung, Taiwan
        • E-DA Hospital
      • Taipei, Taiwan
        • National Taiwan University Hospital
      • Taipei, Taiwan
        • Taipei Medical University Hospital
      • Taipei, Taiwan
        • National Taiwan University Hospital Bei-Hu Branch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female
  • Outpatient or healthy volunteer for health examination, 20~75 years old
  • Eligible for oral bowel preparation
  • BMI (Body Mass Index) ≤ 30

Exclusion Criteria:

  • Patients with severe constipation (as fewer than three stools per week)
  • Patients with bowel obstruction
  • Patients contraindicated with treatment drug
  • Patients who need emergency medication
  • Ineligible for bowel preparation
  • Pregnant or breast-feeding
  • Patients with known allergies to treatment drug or low-residue diet package
  • Patients who are ineligible to enroll

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: low-residue diet package (Enimaclin®)
Low-residue diet package with normal amount 2L PEG-ELS

Enimaclin Colomil ® (Glico Co., Japan Osaka),a low-residue diet package for each meal.

The duration of study is one day before colonoscopy.

Other Names:
  • Enimaclin Colomil ®,a low-residue diet package
Normal volume of PEG-ELS
Other Names:
  • Taiwan name: Niflec powder
Placebo Comparator: Self-controlled diet
Self-controlled diet with normal amount of 2L PEG-ELS
Self-controlled low residue diet.
Other Names:
  • Self-controlled low residue diet.
Normal volume of PEG-ELS
Other Names:
  • Taiwan name: Niflec powder
Experimental: Low-residue diet (Enimaclin®) package
Low-residue diet package with low volume 1.5L PEG-ELS

Enimaclin Colomil ® (Glico Co., Japan Osaka),a low-residue diet package for each meal.

The duration of study is one day before colonoscopy.

Other Names:
  • Enimaclin Colomil ®,a low-residue diet package
Low volume PEG-ELS
Other Names:
  • Taiwan name: Niflec powder

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Cleansing Level at Colonoscopy by Ottawa Bowel Preparation Scale
Time Frame: 1 day
Ottawa preparation scale: Colon is defined into 3 segments: Right(cecum, ascending), mid(transverse, descending), rectosigmoid. Each is scored from 0 to 4, 0 is best and 4 is worst. Fluid quantity of whole is scored as 0, small; 1, moderate; 2 large amount. The scale will be summation of the clearness of 3 segments of colon and overall fluid quantity. It ranged from 0 to 14, 0 is the most clean colon and 14 is the most dirty one. Segment score will be analyzed separately as continuous variable.
1 day
Overall Cleansing Level at Colonoscopy by Aronchick Scale
Time Frame: 1 day

The overall proportion of participants scored as Excellent or Good by Aronchick scale.

Description of Aronchick scale:It categorized colon cleansing into 5 level: Excellent, good, fair, poor, inadequate. It is categorical and cannot be summed. We will present

1 day
Total Volume of Purgatives That Ingested
Time Frame: 1 day
The total volume of PEG-ELS (Liter) that ingested or could be ingested by examinee before colonoscopy
1 day
Segmental Cleansing Level at Colonoscopy (Right Segment Preparation Failure)
Time Frame: 1 day
Segmental score of Ottawa bowel preparation scale was analyzed. The proportion of "right segment" preparation failure, defined as segmental score as "3 poor" or "4 inadequate", was presented.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Willingness to Choose the Same Protocol After Different Low Residual Diet and PEG-ELS Protocol
Time Frame: 1 day
It represent the proportion of participants who wanted to choose the same protocol as they received in this trial.
1 day
Satisfaction of Different Low Residual Diet and Bowel Preparation Protocol
Time Frame: 1 day
It represented the percentage of participants who is satisfied with the protocol.
1 day
Convenience of Different Low Residual Diet and Bowel Preparation Protocol
Time Frame: 1 day
It represented the percentage of participants who thinks the protocol is easy to use.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Han-Mo Chiu, M.D., Ph.D., NTUH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

February 27, 2012

First Submitted That Met QC Criteria

August 13, 2012

First Posted (Estimate)

August 15, 2012

Study Record Updates

Last Update Posted (Estimate)

April 2, 2014

Last Update Submitted That Met QC Criteria

February 18, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • NTUH201109018RD

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dietary Modification

Clinical Trials on Self-controlled diet

Subscribe